Archie Bleyer

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation
    W A Bleyer
    Division of Pediatrics, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Drugs 58:133-40. 1999
  2. ncbi Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials
    W Archie Bleyer
    The University of Texas M D Anderson Cancer Center, The University of Texas Medical School Houston, TX 77030, USA
    Med Pediatr Oncol 38:1-10. 2002
  3. ncbi Older adolescents with cancer in North America deficits in outcome and research
    Archie Bleyer
    The University of Texas M D Anderson Cancer Center, Division of Pediatrics, Houston 77030, USA
    Pediatr Clin North Am 49:1027-42. 2002
  4. ncbi National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation
    Archie Bleyer
    Division of Cancer Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:1891-7. 2005
  5. ncbi Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials
    Archie Bleyer
    Division of Pediatrics, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 107:1645-55. 2006
  6. ncbi The adolescent and young adult gap in cancer care and outcome
    Archie Bleyer
    The University of Texas Anderson Cancer Center, Houston, TX, USA
    Curr Probl Pediatr Adolesc Health Care 35:182-217. 2005
  7. doi Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer
    Anita L Sabichi
    Department of Clinical Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    Clin Cancer Res 14:224-9. 2008
  8. ncbi Proceedings of a workshop: bridging the gap in care and addressing participation in clinical trials
    Archie Bleyer
    The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 107:1656-8. 2006
  9. ncbi A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma
    Jaffer A Ajani
    Department of GI Medical Oncology, University of Texas, M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Invest New Drugs 24:353-7. 2006
  10. ncbi Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
    Yasuhiro Oki
    Department of Lymphoma Myeloma, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 104:781-7. 2005

Detail Information

Publications14

  1. ncbi Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation
    W A Bleyer
    Division of Pediatrics, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Drugs 58:133-40. 1999
    ..Future developments in oral chemotherapy should not be limited to adult patient applications...
  2. ncbi Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials
    W Archie Bleyer
    The University of Texas M D Anderson Cancer Center, The University of Texas Medical School Houston, TX 77030, USA
    Med Pediatr Oncol 38:1-10. 2002
    ..Thus, cancer during adolescence and early adult life is an underestimated challenge that merits specific resources, solutions, and an international focus...
  3. ncbi Older adolescents with cancer in North America deficits in outcome and research
    Archie Bleyer
    The University of Texas M D Anderson Cancer Center, Division of Pediatrics, Houston 77030, USA
    Pediatr Clin North Am 49:1027-42. 2002
    ..Thus, cancer during adolescence and early adulthood has been relatively neglected and merits enhanced national research programs and resources...
  4. ncbi National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation
    Archie Bleyer
    Division of Cancer Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:1891-7. 2005
    ..S. have had less improvement in survival than either younger patients or older patients. The authors attempted to determine whether similar deficits have occurred in young adults with sarcomas and, if so, then why...
  5. ncbi Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials
    Archie Bleyer
    Division of Pediatrics, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 107:1645-55. 2006
    ..National initiatives are underway to address these issues, with special emphasis on increasing the availability and access to clinical trials designed for older adolescents and young adults...
  6. ncbi The adolescent and young adult gap in cancer care and outcome
    Archie Bleyer
    The University of Texas Anderson Cancer Center, Houston, TX, USA
    Curr Probl Pediatr Adolesc Health Care 35:182-217. 2005
  7. doi Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer
    Anita L Sabichi
    Department of Clinical Cancer Prevention, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    Clin Cancer Res 14:224-9. 2008
    ..The study aims to evaluate the efficacy and toxicity of fenretinide in preventing tumor recurrence in patients with transitional cell carcinoma (TCC) of the bladder...
  8. ncbi Proceedings of a workshop: bridging the gap in care and addressing participation in clinical trials
    Archie Bleyer
    The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 107:1656-8. 2006
    ..This may reflect both distinct biologic features of these diseases and a real gap in health care...
  9. ncbi A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma
    Jaffer A Ajani
    Department of GI Medical Oncology, University of Texas, M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Invest New Drugs 24:353-7. 2006
    ..Bryostatin-1 also increases cytotoxicity of paclitaxel in a sequential fashion. We studied sequential paclitaxel and bryostatin-1 in patients with untreated, advanced gastric adenocarcinoma...
  10. ncbi Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
    Yasuhiro Oki
    Department of Lymphoma Myeloma, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 104:781-7. 2005
    ..Oxaliplatin is a platinum derivative with a broad range of anticancer activity. The objective of the current Phase II trial was to investigate the activity of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma (NHL)...
  11. pmc Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial
    Charles Lu
    Department of Thoracic Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX 77030 4009, USA
    J Natl Cancer Inst 102:859-65. 2010
    ..CONCLUSIONS The addition of AE-941 to chemoradiotherapy did not improve overall survival in patients with unresectable stage III NSCLC. This study does not support the use of shark cartilage-derived products as therapy for lung cancer...
  12. ncbi Birth weight, ethnicity, and occurrence of cancer in children: a population-based, incident case-control study in the State of Texas, USA
    Mehmet Fatih Okcu
    Division of Pediatrics, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Cancer Causes Control 13:595-602. 2002
    ....
  13. ncbi Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group
    Mary Johansen
    Division of Pharmacy, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin Cancer Res 12:516-22. 2006
    ..We conducted a phase I study of vinorelbine given the activity of Vinca alkaloids in many pediatric tumors...
  14. ncbi Homebound schooling is the least favorable option for continued education of adolescent cancer patients: a preliminary report
    Nancy S Searle
    Office of Curriculum, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA
    Med Pediatr Oncol 40:380-4. 2003
    ....